Search

Your search keyword '"Papi, L"' showing total 364 results

Search Constraints

Start Over You searched for: Author "Papi, L" Remove constraint Author: "Papi, L"
364 results on '"Papi, L"'

Search Results

1. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

3. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

8. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

11. Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

12. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

15. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

16. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

17. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

18. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

19. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

20. The spectrum of fancm protein truncating variants in European breast cancer cases.

21. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

22. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

23. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

24. The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases

33. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

34. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

35. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

36. Accounting for Power and Resistance: the University of Ferrara under the Fascist Regime in Italy

37. Public value and public sector accounting research: a structured literature review

40. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

41. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

42. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

43. Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants

44. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

46. Primary Ampullary Adenocarcinoma and Von Recklinghausen’s Disease: A Rare Association

47. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

50. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

Catalog

Books, media, physical & digital resources